{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:07:07Z","timestamp":1766268427577,"version":"3.41.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Primary cutaneous CD4<jats:sup>+<\/jats:sup> small\/medium T-cell lymphoproliferative disorder (PCSM-LPD), recently downgraded from a T-cell lymphoma, is a poorly characterized histopathological entity. Presenting as a solitary lesion that often grows rapidly, it may raise suspicion for a cutaneous B-cell lymphoma. However, classically, the dermal lymphoid proliferation is predominantly CD4<jats:sup>+<\/jats:sup> with a follicular T-helper profile and a smaller B-cell fraction. Diagnostic uncertainty may arise when B cells are present in large numbers, a B-cell clone is present, or large cell populations are seen. To meet the diagnostic criterion of PCSM-LPD, large cells should not constitute more than 30% of the infiltrate. The 2 cases presented in this article caused diagnostic uncertainty owing to the observation of high numbers of large cells and in one case the presence of a B-cell clone, on the background of otherwise typical clinicopathological features of PCSM-LPD. We review the literature specifically regarding the prevalence of large cell populations and their immunophenotypic characteristics and in light of this discuss whether a current diagnostic criterion should be reconsidered.<\/jats:p>","DOI":"10.1097\/dad.0000000000001979","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T18:01:11Z","timestamp":1621015271000},"page":"e190-e196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Prominent Blasts in Primary Cutaneous CD4+ Small\/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria"],"prefix":"10.1097","volume":"43","author":[{"given":"Farrah","family":"Bakr","sequence":"first","affiliation":[{"name":"Department of Dermatology, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Mary","family":"Wain","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Wong","sequence":"additional","affiliation":[{"name":"Consultant Dermatologist, HCA UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Princess Margaret Hospital, Windsor, Berkshire, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair","family":"Robson","sequence":"additional","affiliation":[{"name":"Consultant Dermatopathologist, LD Path, London, United Kingdom; and"},{"name":"Servi\u00e7o de Anatomia Patol\u00f3gica, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R3-20250616","first-page":"123","article-title":"Primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoproliferative disorder: where do we stand? A systematic review","volume":"17","author":"Salah","year":"2019","journal-title":"J Ger Soc Dermatol."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaad.2018.05.033","article-title":"Management of primary cutaneous CD4+ small and medium pleomorphic T-cell lymphoma: a retrospective study","volume":"79","author":"Yuan","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/DAD.0b013e3182a74c7a","article-title":"Multicenter case series of indolent small\/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face","volume":"36","author":"Li","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/DAD.0b013e31825c3a33","article-title":"Primary cutaneous CD8+ small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification","volume":"35","author":"Kempf","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.dad.0000210389.36724.dd","article-title":"Pleomorphic CD8+ small\/medium size cutaneous T-cell lymphoma","volume":"28","author":"Khamaysi","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1034\/j.1600-0560.2002.290804.x","article-title":"Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas","volume":"29","author":"Lu","year":"2002","journal-title":"J Cutan Pathol."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2340\/00015555-2002","article-title":"Disseminated primary cutaneous CD8+ small\/medium-sized pleomorphic T-cell lymphoma responding to hydroxychloroquine","volume":"95","author":"Amann","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R10-20250616","first-page":"602","article-title":"A case of CD8+ small\/medium-sized pleomorphic T-cell lymphoma: clinical and histopathological differential diagnosis","volume":"95","author":"Kutlubay","year":"2014","journal-title":"Br J Dermatol"},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.1711720110","article-title":"Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and cd30-positive large cell lymphoma","volume":"172","author":"Beljaards","year":"1994","journal-title":"J Pathol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","article-title":"Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodr\u00edguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","article-title":"Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic t-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma","volume":"36","author":"\u00c7etin\u00f6zman","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"R16-20250616","first-page":"522","article-title":"Primary cutaneous CD4(+) small\/medium-sized T-cell lymphoma of the face: successful treatment with radiation therapy","volume":"14","author":"Topal","year":"2016","journal-title":"J Dtsch Dermatolo Ges"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/cup.13011","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoproliferative disorder: report of a case and review of the literature","volume":"44","author":"Keeling","year":"2017","journal-title":"J Cutan Pathol."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/PAS.0000000000001470","article-title":"Primary cutaneous CD4+Small\/medium T-cell lymphoproliferative disorders: a clinical, pathologic, and molecular study of 60 cases presenting with a single lesion: a multicenter study of the French cutaneous lymphoma study group","volume":"44","author":"Beltzung","year":"2020","journal-title":"Am J Surg Pathol."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.anndiagpath.2017.04.009","article-title":"CD30 + T cell enriched primary cutaneous CD4 + small\/medium sized pleomorphic T cell lymphoma: a distinct variant of indolent CD4 + T cell lymphoproliferative disease","volume":"30","author":"Magro","year":"2017","journal-title":"Ann Diagn Pathol."},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/cup.12169","article-title":"Primary cutaneous CD4 positive small\/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells","volume":"40","author":"Zhang","year":"2013","journal-title":"J Cutan Pathol."},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol."},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1346-8138.14916","article-title":"Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy","volume":"46","author":"Sato-Sano","year":"2019","journal-title":"J Dermatol."},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2010.07.028","article-title":"Reappraisal of the provisional entity primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature","volume":"65","author":"Baum","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000212118","article-title":"Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases","volume":"219","author":"Leinweber","year":"2009","journal-title":"Dermatology"},{"key":"R25-20250616","first-page":"389","article-title":"Primary cutaneous small- to medium-sized CD4 pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category","volume":"12","author":"Williams","year":"2011","journal-title":"Am J Clin Dermatol."},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/DAD.0000000000000596","article-title":"Cutaneous small\/medium CD4+ pleomorphic T-cell lymphoma-like nodule in a patient with erythema chronicum migrans","volume":"38","author":"Celebi Cherukuri","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/DAD.0000000000000987","article-title":"Cutaneous richter syndrome mimicking primary cutaneous CD4-Positive small\/Medium T-cell lymphoma: case report and review of the literature","volume":"40","author":"Rito","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"R28-20250616","article-title":"Angioimmunoblastic T-cell lymphoma: dermatopathological features in a series of 40 cases","author":"Elbendary","year":"2011","journal-title":"Lab Investig."},{"key":"R29-20250616","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2559.2007.02632.x","article-title":"Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics","volume":"50","author":"Attygalle","year":"2007","journal-title":"Histopathology"},{"key":"R30-20250616","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2353\/jmoldx.2006.060016","article-title":"The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations","volume":"8","author":"Tan","year":"2006","journal-title":"J Mol Diagn."},{"key":"R31-20250616","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/cup.12234","article-title":"Evaluation of follicular T-helper cells in primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoma and dermatitis","volume":"40","author":"Ally","year":"2013","journal-title":"J Cutan Pathol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T20:00:39Z","timestamp":1750104039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001979","relation":{},"ISSN":["0193-1091"],"issn-type":[{"type":"print","value":"0193-1091"}],"subject":[],"published":{"date-parts":[[2021,5,11]]}}}